Evaluation of oral mucositis, candidiasis, and quality of life in patients with head and neck cancer treated with a hypofractionated or conventional radiotherapy protocol: a longitudinal, prospective, observational study

[1]  I. Chitapanarux,et al.  An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an observation study , 2021, BMC oral health.

[2]  N. Magné,et al.  Mechanisms of PhotoBioModulation (PBM) focused on oral mucositis prevention and treatment: a scoping review , 2021, BMC oral health.

[3]  L. Potters,et al.  Impact of the COVID-19 Pandemic Surge on Radiation Treatment: Report From a Multicenter New York Area Institution. , 2021, JCO oncology practice.

[4]  D. Blakaj,et al.  Emerging Concepts and Novel Strategies in Radiation Therapy for Laryngeal Cancer Management , 2020, Cancers.

[5]  R. Gilbert,et al.  Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID‐19 pandemic: The Princess Margaret experience and proposal , 2020, Cancer.

[6]  L. Potters,et al.  Guidelines to Reduce Hospitalization Rates for Patients Receiving Curative-Intent Radiation Therapy During the COVID-19 Pandemic: Report From a Multicenter New York Area Institution , 2020, Advances in Radiation Oncology.

[7]  G. Viani,et al.  Evaluation of the correlation between side effects to oral mucosa, salivary glands, and general health status with quality of life during intensity-modulated radiotherapy for head and neck cancer , 2020, Supportive Care in Cancer.

[8]  C. Wang,et al.  Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China , 2020, Annals of Oncology.

[9]  A. Ravaud,et al.  The official French guidelines to protect patients with cancer against SARS-CoV-2 infection , 2020, The Lancet Oncology.

[10]  M. Chua,et al.  SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China , 2020, JAMA oncology.

[11]  V. Tombolini,et al.  The impact of Coronavirus (COVID-19) on head and neck cancer patients’ care☆ , 2020, Radiotherapy and Oncology.

[12]  Ruchong Chen,et al.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China , 2020, The Lancet Oncology.

[13]  A. Sultan,et al.  Oral Candidiasis: A Disease of Opportunity , 2020, Journal of fungi.

[14]  S. Kandasamy,et al.  Effect of Hypofractionated, Palliative Radiotherapy on Quality of Life in Late-Stage Oral Cavity Cancer: A Prospective Clinical Trial , 2019, Indian journal of palliative care.

[15]  I. Pereira,et al.  Radiation-induced Oral Mucositis in Brazilian Patients: Prevalence and Associated Factors , 2019, In Vivo.

[16]  S. Billan,et al.  Precision medicine in head and neck cancer. , 2018, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[17]  M. Parmar,et al.  Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. , 2017, The Lancet. Oncology.

[18]  L. Moura,et al.  Protocols for management of oral complications of chemotherapy and/or radiotherapy for oral cancer: Systematic review and meta-analysis current , 2016, Medicina oral, patologia oral y cirugia bucal.

[19]  A. Forastiere,et al.  Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. , 2016, Mayo Clinic proceedings.

[20]  S. L. Kurtz,et al.  Oral adverse events in cancer patients treated with VEGFR-directed multitargeted tyrosine kinase inhibitors. , 2015, Oral oncology.

[21]  Y. Jiménez-Soriano,et al.  Clinical and microbiological diagnosis of oral candidiasis , 2013, Journal of clinical and experimental dentistry.

[22]  D. Kutler,et al.  Radiation therapy is well tolerated and produces excellent control rates in elderly patients with locally advanced head and neck cancers. , 2012, Journal of geriatric oncology.

[23]  F. Spijkervet,et al.  A systematic review of oral fungal infections in patients receiving cancer therapy , 2010, Supportive Care in Cancer.

[24]  S. Sonis.  Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. , 2009, Oral oncology.

[25]  B. Maciejewski,et al.  Randomized clinical trial on 7-days-a-week postoperative radiotherapy for high-risk squamous cell head and neck cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  A. Garden,et al.  Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. , 2007, International journal of radiation oncology, biology, physics.

[27]  L. Kowalski,et al.  Candida oral colonization and infection in Brazilian patients undergoing head and neck radiotherapy: a pilot study. , 2007, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[28]  L. Kowalski,et al.  Brazilian–Portuguese validation of the University of Washington Quality of Life Questionnaire for patients with head and neck cancer , 2006, Head & neck.

[29]  G. V. Ramana,et al.  Chemotherapy-induced and/or radiation therapy-induced oral mucositis--complicating the treatment of cancer. , 2004, Neoplasia.

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[31]  P. Fayers,et al.  A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. , 2000, European journal of cancer.

[32]  J. Wilkes.  Prevention and treatment of oral mucositis following cancer chemotherapy. , 1998, Seminars in oncology.

[33]  J. Epstein,et al.  Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck. , 1993, Oral surgery, oral medicine, and oral pathology.

[34]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[35]  J. Bourhis,et al.  Radiation therapy for head and neck cancers in the elderly. , 1990, International journal of radiation oncology, biology, physics.

[36]  R. D. Hunter,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1980 .